International Journal Of Pharmaceutics

International Journal Of Pharmaceutics

国际药剂学杂志

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《International Journal Of Pharmaceutics》是由Elsevier出版社于1978年创办的英文国际期刊(ISSN: 0378-5173,E-ISSN: 1873-3476),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0238...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比95.75%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在988篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

International Journal Of Pharmaceutics审稿周期约为 约2.5个月 约4.8周。该刊近年未被列入国际预警名单,年发文量约988篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 988 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 34 / 354

90.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 23 / 354

93.64%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.7 SJR:0.954 SNIP:1.132
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 15 / 183

92%

期刊发文

  • Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza

    Author: Guo, Ziyan; Jing, Qiufang; Xu, Zhongyu; Zhang, Dahe; Zheng, Wenyun; Ren, Fuzheng

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 638, Issue , pp. -. DOI: 10.1016/j.ijpharm.2023.122914

  • Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent

    Author: Shen, Rui; Chen, Yuhong; Li, Xiangyu; Wang, Xi; Yang, Aihong; Kou, Xiaodi

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 630, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122458

  • Rucaparib cocrystal: Improved solubility and bioavailability over camsylate

    Author: Xia, Mengyuan; Jiang, Yihua; Cheng, Yinxiang; Dai, Wenjuan; Rong, Xiaoyi; Zhu, Bingqing; Mei, Xuefeng

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122461

  • Plasma metabolites-based design of long-acting peptides and their anticancer evaluation

    Author: Zhang, Chenyu; Li, Xiang; Xing, Zhenjian; Zhong, Honglan; Yu, Dianbao; Yu, Rui; Deng, Xin

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122483

  • 3D printing: Innovative solutions for patients and pharmaceutical industry

    Author: Tracy, Timothy; Wu, Lei; Liu, Xin; Cheng, Senping; Li, Xiaoling

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122480

  • Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury

    Author: Zhang, Hongqian; Ding, Feng; Zhu, Zongwei; Sun, Qian; Yang, Chuanxu

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122489

  • Persistent immune response: Twice tumor exfoliation induced by sialic acid-modified vincristine sulfate liposomes

    Author: Yan, Xinyang; Gao, Xin; Li, Xiaoya; Qiu, Qiujun; Li, Cong; Yan, Na; Li, Jie; Liu, Mengyang; Tang, Xueying; Liu, Xinrong; Song, Yanzhi; Deng, Yihui

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122467

  • Multistage O-2-producing liposome for MRI-guided synergistic chemodynamic/chemotherapy to reverse cancer multidrug resistance

    Author: Liang, Yan; Wang, Ping-Yu; Li, You-Jie; Liu, Ze-Yun; Wang, Ran-Ran; Sun, Guang-Bin; Sun, Hong-Fang; Xie, Shu-Yang

    Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2023; Vol. 631, Issue , pp. -. DOI: 10.1016/j.ijpharm.2022.122488